InStride Health Secures $30 Million in Latest Series C Funding Round

InStride Health secured $30 million in its latest Series C, adding another data point to the Healthcare & Life Sciences funding market.

InStride Health Raises $30 million in Funding

InStride Health lands $30M series C to expand pediatric mental health services.

Investors Behind the Funding

The round was backed by undisclosed investors. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

InStride Health operates in Healthcare & Life Sciences. InStride Health's Series C round shows investors are still backing digital health platforms with real scale narratives. At $30M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Expand pediatric mental health services.

Looking Ahead

InStride Health lands $30M series C to expand pediatric mental health services

Source reference: original announcement/article.